Dr. Emma Allen-Vercoe
Department of Molecular & Cellular Biology, University of Guelph, Guelph, Canada.
Dr. Allen-Vercoe’s research focuses on the study of the normal human gut microflora, both in disease and in health. She focuses on 2 key diseases with connections to gut microflora: Inflammatory Bowel Disease (Crohn’s and ulcerative colitis), and regressive autism. Allen-Vercoe’s research seeks to further characterize the microflora of autistic patients, and to determine whether certain bacterial products may somehow be involved in the etiology of autism. Her laboratory is collaborating with The Broad Institute of MIT and Harvard to contribute to the human microbiome project.
Prof. Jeremy Nicholson
Chair In Biological Chemistry, Head of Department, Department of Surgery and Cancer, Imperial College, London UK
Prof. Nicholson is a multi-award winning biochemist, who was one of the first to embrace the importance of metabolic profiling. Prof. Nicholson’s research involves understanding the role of microbes in regulating human metabolic pathways and how the microbes are involved in drug metabolism toxicity as well as variations in therapeutic responses. A major challenge in Professor Nicholson’s work is being able to characterize and classify hundreds of thousands of molecules produced by the metabolic system.
Dr. Stephen Scherer
Director of The Centre for Applied Genomics, and Senior Scientist, The Hospital for Sick Children, Toronto, Canada
Dr. Scherer has won numerous honors, and leads one of Canada’s busiest laboratories. His group has discovered numerous disease susceptibility genes and most recently has defined several genetic factors underlying autism. He has contributed to generating the first genome sequence of an individual, and some 300 scientific papers document his work.
Dr. Derrick MacFabe
Director and Principal Investigator of the Kilee-Patchell-Evans Autism Research Group, University of Western Ontario, London, Canada.
Departments of Psychology (Neuroscience) & Psychiatry (Division of Developmental Disabilities).
Dr. MacFabe has a particular interest in the role of pre and post natal infectious processes in the etiology and behaviours of autism spectrum disorders. As a principal investigator at the Kilee Patchell-Evans Autism Research Group he is actively contributing to the development of novel animal models as well as the role of genetics, biochemistry and environment on the identification and possible treatments of autism spectrum disorders. In 2007, work on autism by his research group was listed among the top 50 scientific discoveries in Canada by the National Sciences and Engineering Research Council of Canada (NSERC).